BCL2 and leukemia: By employing a large-scale drug screening, we discovered that inhibitors of PI3K pathway, MAPK pathway, BCL2 family, and HDAC were found to significantly suppressed in vitro proliferation of leukemia cells harboring the MEF2D fusion gene (Fig. 1d and Supplementary Fig. 1b, c).